# MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4
> **ANDA215371** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2022-06-08
## Drug
- **FDA Application Number:** ANDA215371
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP PH 7.4
- **Generic name:** SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE
- **Active ingredients:** MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-06-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215371)
---
*MORVS · CC0 1.0*